Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Holmes, Kyland P ^a   Fang, John C ^b   Jackson, Brian R ^a,b  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; COMPARATIVE STUDY; COST; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; DYSPEPSIA; ECONOMICS; FEMALE; HEALTH CARE PLANNING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; SEROLOGY; STANDARD; STATISTICS; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DISEASE MANAGEMENT; DYSPEPSIA; FEMALE; HEALTH RESOURCES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROTON PUMP INHIBITORS; SEROLOGIC TESTS; UNITED STATES;

EID: 78650262728     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-344     Document Type: Article

References (57)

1. American gastroenterological association technical review on the evaluation of dyspepsia. NJ Talley NB Vakil P Moayyedi, Gastroenterology 2005 129 5 1756 80 10.1053/j.gastro.2005.09.020 16285971
2. American Gastroenterological Association medical position statement: evaluation of dyspepsia. NJ Talley, Gastroenterology 2005 129 5 1753 5 10.1053/j.gastro.2005.09.019 16285970
3. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. WD Chey BC Wong, Am J Gastroenterol 2007 102 8 1808 25 10.1111/j.1572-0241.2007.01393.x 17608775
4. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. I Adamsson CE Nord P Lundquist S Sjostedt C Edlund, J Antimicrob Chemother 1999 44 5 629 40 10.1093/jac/44.5.629 10552979
5. Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora. I Adamsson C Edlund CE Nord, Clin Microbiol Infect 2000 6 4 175 7 10.1111/j.1469-0691.2000.00028.x 11168104
6. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. X Calvet E Gene T Lopez JP Gisbert, Aliment Pharmacol Ther 2001 15 7 1067 76 10.1046/j.1365-2036.2001. 01031.x 11421884
7. The management of Helicobacter pylori infection in primary care: a systematic review of the literature. S Childs A Roberts V Meineche-Schmidt WN de G Rubin, Fam Pract 2000 17 Suppl 2 6 11 10.1093/fampra/17.suppl-2.S6 10960429
8. Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. J Choi JY Jang JS Kim HY Park YH Choe KM Kim, J Korean Med Sci 2006 21 6 1037 40 10.3346/jkms.2006.21.6.1037 17179683
9. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease. AF Cutler N Vakil, Am J Manag Care 1997 3 10 1528 34 10178459
10. Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model. AE Duggan K Tolley CJ Hawkey RF Logan, BMJ 1998 316 7145 1648 54 9603748
11. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. AC Ford BC Delaney D Forman P Moayyedi, Am J Gastroenterol 2004 99 9 1833 55 10.1111/j.1572-0241.2004.40014.x 15330927
12. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. L Laine P Schoenfeld MB Fennerty, Ann Intern Med 2001 134 5 361 9 11242496
13. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. P Malfertheiner F Megraud C O'Morain AP Hungin R Jones A Axon,, et al. Aliment Pharmacol Ther 2002 16 2 167 80 10.1046/j.1365-2036.2002.01169.x 11860399
14. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. P Malfertheiner F Megraud C O'Morain F Bazzoli E El-Omar D Graham,, et al. Gut 2007 56 6 772 81 10.1136/gut.2006.101634 17170018
15. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. KE McColl A Dickson A El-Nujumi E El-Omar A Kelman, Am J Gastroenterol 2000 95 1 101 5 10638566
16. Helicobacter pylori infection and long term proton pump inhibitor therapy. KE McColl, Gut 2004 53 1 5 7 10.1136/gut.53.1.5 14684566
17. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. P Moayyedi S Soo J Deeks D Forman J Mason M Innes,, et al. BMJ 2000 321 7262 659 64 10.1136/bmj.321.7262.659 10987767
18. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. P Moayyedi J Deeks NJ Talley B Delaney D Forman, Am J Gastroenterol 2003 98 12 2621 6 10.1111/j.1572-0241.2003.08724.x 14687807
19. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. AS Raghunath AP Hungin D Wooff S Childs, Aliment Pharmacol Ther 2004 20 7 733 44 10.1111/j.1365-2036.2004.02172.x 15379833
20. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer. A Sonnenberg MP Pauly SD Levenson JS Schwartz, Am J Manag Care 1999 5 1 53 9 10345967
21. Dyspepsia management in primary care: a decision analysis of competing strategies. BM Spiegel NB Vakil JJ Ofman, Gastroenterology 2002 122 5 1270 85 10.1053/gast.2002.33019 11984514
22. Guidelines for the management of dyspepsia. NJ Talley N Vakil, Am J Gastroenterol 2005 100 10 2324 37 10.1111/j.1572-0241.2005.00225.x 16181387
23. Treatment of Helicobacter pylori infection: management of patients with ulcer disease by general practitioners and gastroenterologists. GN Tytgat, Gut 1998 43 Suppl 1 24 S26 10.1136/gut.43.2008.S24 9764035
24. Helicobacter pylori eradication: equivalence trials and the optimal duration of therapy. N Vakil J Connor, Am J Gastroenterol 2005 100 8 1702 3 10.1111/j.1572-0241.2005.50615.x 16144122
25. Eradication therapy for Helicobacter pylori. N Vakil F Megraud, Gastroenterology 2007 133 3 985 1001 10.1053/j.gastro.2007.07.008 17854602
26. Noninvasive Helicobacter pylori testing for the "testand-treat" strategy: a decision analysis to assess the effect of past infection on test choice. WD Chey AM Fendrick, Arch Intern Med 2001 161 17 2129 32 10.1001/archinte.161.17.2129 11570943
27. Comparison of invasive methods and two different stool antigen tests for diagnosis of H pylori infection in patients with gastric bleeding. E Demiray O Yilmaz C Sarkis M Soyturk I Simsek, World J Gastroenterol 2006 12 26 4206 10 16830376
28. Cost analysis of breath test versus endoscopy for dyspepsia. I Gee RJ Playford D Turner N Sheldon AC Wicks, Digestion 2002 65 4 207 12 10.1159/000063821 12239461
29. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. PI Hsu KH Lai HH Tseng YC Liu MY Yen CK Lin,, et al. J Clin Gastroenterol 1997 25 4 587 91 10.1097/00004836-199712000-00007 9451668
30. Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection. F Lehmann J Drewe L Terracciano R Stuber R Frei C Beglinger, BMJ 1999 319 7222 1409 10574858
31. Evaluation of invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. SK Ogata E Kawakami FR Patricio MZ Pedroso AM Santos, Sao Paulo Med J 2001 119 2 67 71 10.1590/S1516-31802001000200006 11276169
32. Histology compared with chemical testing for urease for rapid detection of Helicobacter pylori in gastric biopsy specimens. AM Zaitoun, J Clin Pathol 1993 46 7 684 5 10.1136/jcp.46.7.684 8157765
33. Comparison of three stool antigen tests for Helicobacter pylori detection. J Andrews B Marsden D Brown VS Wong E Wood M Kelsey, J Clin Pathol 2003 56 10 769 71 10.1136/jcp.56.10.769 14514781
34. Comparison of new faecal antigen test with (13)C-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation. B Braden G Teuber CF Dietrich WF Caspary B Lembcke, BMJ 2000 320 7228 148 10.1136/bmj.320.7228.148 10634733
35. Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A pilot study. JP Gisbert M Trapero JM Pajares, Gastroenterol Hepatol 2005 28 10 615 8 10.1016/S0210-5705(05)71524-7 16373010
36. Accuracy of CLOtest after Helicobacter pylori therapy. L Laine L Suchower E Johnson P Ronca G Neil, Gastrointest Endosc 1998 47 3 250 3 10.1016/S0016-5107(98)70321-9 9540877
37. Clinical value of Helicobacter pylori stool antigen test, ImmunoCard STAT HpSA, for detecting H pylori infection. YH Li H Guo PB Zhang XY Zhao SP Da, World J Gastroenterol 2004 10 6 913 4 15040045
38. Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests. TG Reilly V Poxon DS Sanders TS Elliott RP Walt, Gut 1997 40 4 454 8 9176070
39. Efficacy of noninvasive tests in the diagnosis of Helicobacter pylori infection in pediatric patients. T Sabbi AP De F Colistro L Dall'Oglio GF di Abriola M Castro, Arch Pediatr Adolesc Med 2005 159 3 238 41 10.1001/archpedi.159.3.238 15753266
40. Comparison of an enzyme immunoassay for the detection of Helicobacter pylori antigens in the faeces with the urea breath test. AJ Shepherd CL Williams CP Doherty M Hossack T Preston KE McColl,, et al. Arch Dis Child 2000 83 3 268 70 10.1136/adc.83.3.268 10952653
41. Blood, urine, stool, breath, money, and Helicobacter pylori. D Vaira N Vakil, Gut 2001 48 3 287 9 10.1136/gut.48.3.287 11171812
42. The stool antigen test for detection of Helicobacter pylori after eradication therapy. D Vaira N Vakil M Menegatti HB van't C Ricci L Gatta,, et al. Ann Intern Med 2002 136 4 280 7 11848725
43. Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy. L Veijola E Myllyluoma R Korpela H Rautelin, World J Gastroenterol 2005 11 46 7340 4 16437639
44. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori. N Vakil D Rhew A Soll JJ Ofman, Am J Gastroenterol 2000 95 7 1691 8 10925969
45. Costeffectiveness of diagnostic tests. AI Mushlin HS Ruchlin MA Callahan, Lancet 2001 358 9290 1353 5 10.1016/S0140-6736(01)06417-0 11684235
46. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. A Raghunath AP Hungin D Wooff S Childs, BMJ 2003 326 7392 737 10.1136/bmj.326.7392.737 12676842
47. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. JE Crabtree TM Shallcross RV Heatley JI Wyatt, J Clin Pathol 1991 44 4 326 8 10.1136/jcp.44.4.326 2030153
48. Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. Conflicting results from the Helisal test. A Duggan R Logan, BMJ 1997 314 7095 1688 9 9193298
49. Use of serum-specific immunoglobulins A and G for detection of Helicobacter pylori infection in patients with chronic gastritis by immunoblot analysis. S Karvar H Karch M Frosch W Burghardt U Gross, J Clin Microbiol 1997 35 12 3058 61 9399494
50. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. NJ Talley DG Newell JE Ormand HA Carpenter WR Wilson AR Zinsmeister,, et al. J Clin Microbiol 1991 29 8 1635 9 1761685
51. Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection. EA van Der RW van Der Hulst P Roorda GN Tytgat J Dankert, J Clin Microbiol 1999 37 12 4150 2 10565949
52. Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy. Y Erzin S Altun A Dobrucali M Aslan S Erdamar A Dirican,, et al. J Med Microbiol 2005 54 Pt 9 863 6 10.1099/jmm.0.45914-0 16091438
53. Diagnosis of Helicobacter pylori infection by stool antigen determination: a systematic review. JP Gisbert JM Pajares, Am J Gastroenterol 2001 96 10 2829 38 10.1111/j.1572-0241.2001.04235.x 11693315
54. Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. JP Gisbert JM Pajares, Helicobacter 2004 9 4 347 68 10.1111/j.1083-4389.2004.00235.x 15270750
55. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. JP Gisbert MF de la V Abraira, Am J Gastroenterol 2006 101 8 1921 30 10.1111/j.1572-0241.2006.00668.x 16780557
56. Accuracy of Helicobacter pylori stool antigen for the detection of Helicobacter pylori infection in dyspeptic patients. AF Syam AA Rani M Abdullah C Manan D Makmun M Simadibrata,, et al. World J Gastroenterol 2005 11 3 386 8 15643676
57. Eradication of Helicobacter pylori for non-ulcer dyspepsia. P Moayyedi S Soo J Deeks B Delaney A Harris M Innes,, et al. Cochrane Database Syst Rev 2006 2 D002096 16625554